Cargando…

Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis

In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Munir, Farrukh, Javaid, Hafiza Wajeeha, Rana, Muhammad Burhan Majeed, Shaukat, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012477/
https://www.ncbi.nlm.nih.gov/pubmed/35449634
http://dx.doi.org/10.7759/cureus.23226
_version_ 1784687804924559360
author Munir, Farrukh
Javaid, Hafiza Wajeeha
Rana, Muhammad Burhan Majeed
Shaukat, Fatima
author_facet Munir, Farrukh
Javaid, Hafiza Wajeeha
Rana, Muhammad Burhan Majeed
Shaukat, Fatima
author_sort Munir, Farrukh
collection PubMed
description In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity.
format Online
Article
Text
id pubmed-9012477
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90124772022-04-20 Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis Munir, Farrukh Javaid, Hafiza Wajeeha Rana, Muhammad Burhan Majeed Shaukat, Fatima Cureus Internal Medicine In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity. Cureus 2022-03-16 /pmc/articles/PMC9012477/ /pubmed/35449634 http://dx.doi.org/10.7759/cureus.23226 Text en Copyright © 2022, Munir et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Munir, Farrukh
Javaid, Hafiza Wajeeha
Rana, Muhammad Burhan Majeed
Shaukat, Fatima
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title_full Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title_fullStr Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title_full_unstemmed Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title_short Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
title_sort ceftriaxone-induced reversible agranulocytosis: a case report and review of drug-induced agranulocytosis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012477/
https://www.ncbi.nlm.nih.gov/pubmed/35449634
http://dx.doi.org/10.7759/cureus.23226
work_keys_str_mv AT munirfarrukh ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis
AT javaidhafizawajeeha ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis
AT ranamuhammadburhanmajeed ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis
AT shaukatfatima ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis